You are here


Our biopharmaceutical businesses include our Pfizer Innovative Health , Pfizer Essential Health, Vaccines and Oncology business.

These businesses are generally responsible for late-stage clinical development of medicines that have advanced to at least phase 2b of clinical development, having achieved earlier stages of pre-identified safety and efficacy measures. 

With each business focusing on global but specific areas of medicine and related-services, our unique structure allows us to be more responsive and flexible to the needs of our partners.


Pfizer Innovative Health

At Pfizer, putting the patient first drives our passion, inspires us to collaborate, and motivates us to create and innovate. For the newly formed Pfizer Innovative Health, this belief represents something even more: it defines how we organize ourselves and evaluate performance. Most of all, it holds us accountable for creating a healthier world



Pfizer's Vaccines business is one of the industry’s largest, with more than $4 billion in global revenue.



Pfizer Oncology is striving to cure or control cancer with innovative medicines.


Pfizer Essential Health

At Pfizer Essential Health we combine our history of industry leadership, comprehensive knowledge of global healthcare markets, and vast portfolio of trusted, quality medicines to benefit patients around the world at virtually every stage of life.